Endeavour Announces Holding(s) in Company
July 26, 2024 10:34 ET
|
Endeavour Mining PLC
Endeavour Mining plc (“the Company”) announces that it received the following notification today, 26 July 2024 from Blackrock, Inc. of its interests in the Company as at 25 July 2024 TR-1: Standard...
DFDS FORLADER SPACE CHARTER AFTALE PÅ DOVER-CALAIS
July 26, 2024 10:00 ET
|
DFDS A/S
INVESTOR NEWS nr. 54 - 26. juli 2024 DFDS vil forlade space charteraftalen med P&O Ferries, der omfatter Dover-Calais-ruten, med virkning fra slutningen af august 2024. Space charteraftalen...
DFDS TO LEAVE SPACE CHARTER AGREEMENT ON DOVER-CALAIS
July 26, 2024 10:00 ET
|
DFDS A/S
INVESTOR NEWS no. 54 - 26 July 2024 DFDS will leave the space charter agreement with P&O Ferries covering the Dover-Calais route effective from end August 2024. The space charter agreement...
Allotment of Shares under DRIS
July 26, 2024 09:53 ET
|
Hargreave Hale AIM VCT plc
26 July 2024 HARGREAVE HALE AIM VCT PLC(the “Company”) Allotment of Shares under DRIS The Company has today allotted 2,235,192 Ordinary Shares pursuant to its Dividend Re-Investment Scheme...
Orange: Publication of Orange’s 2024 interim financial report
July 26, 2024 09:22 ET
|
Orange
Press release Paris, 26 July 2024 Publication of Orange’s 2024 interim financial report Orange announces the publication of its first half 2024 financial report. The report was...
Medical Billing Market: $16.8B to $27.7B Growth Forecast (2024-2029) | MarketsandMarkets™
July 26, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, July 26, 2024 (GLOBE NEWSWIRE) -- The "Medical Billing Market Size, Share & Trends by Product (Software, Service), Application (RCM, EHR, Practice Management), Type (Account receivable,...
GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive
July 26, 2024 07:45 ET
|
GENFIT S.A.
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), 26 juillet 2024 - GENFIT (Nasdaq et Euronext : GNFT), une société biopharmaceutique de stade clinique avancé engagée dans...
GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis
July 26, 2024 07:45 ET
|
GENFIT S.A.
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 26, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the...
Issue of Equity - DRIS
July 26, 2024 07:44 ET
|
Thames Ventures VCT 1 plc
THAMES VENTURES VCT 1 PLCLEI: 213800R88MRC4Y3OIW86 26 July 2024Issue of EquityDividend Reinvestment Scheme The Board announces that on 26 July 2024 691,312 Ordinary Shares of 1p each in the Company...
ERRATUM : Chiffre d’affaires du 1er semestre 2024 : 129,9 M€ (+3%)
July 26, 2024 06:45 ET
|
Aurea
ERRATUM : Chiffre d’affaires du 1er semestre 2024 : 129,9 M€ (+3%) Dans le communiqué de presse intitulé « Chiffre d’affaires du 1er semestre 2024 : 129,9 M€ (+3%) » diffusé le 25/07/2024 à 18h00,...